Robbins Arroyo LLP Is Investigating the Officers and Directors of The Spectranetics Corporation (SPNC) on Behalf of Shareholders
Robbins Arroyo LLP is investigating claims that certain officers and directors of The Spectranetics Corporation (NASDAQGS: SPNC) violated the Securities Exchange Act of 1934 by making materially false and misleading statements about Spectranetics’ business prospects. Spectranetics, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system.
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.
Send This Post